Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Therapeutic strategies for spinal muscular atrophy: SMN and beyond.

Bowerman M, Becker CG, Yáñez-Muñoz RJ, Ning K, Wood MJA, Gillingwater TH, Talbot K; UK SMA Research Consortium.

Dis Model Mech. 2017 Aug 1;10(8):943-954. doi: 10.1242/dmm.030148. Review.

2.

Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy.

Kaifer KA, Villalón E, Osman EY, Glascock JJ, Arnold LL, Cornelison DD, Lorson CL.

JCI Insight. 2017 Mar 9;2(5):e89970. doi: 10.1172/jci.insight.89970.

3.

Developing therapies for spinal muscular atrophy.

Wertz MH, Sahin M.

Ann N Y Acad Sci. 2016 Feb;1366(1):5-19. doi: 10.1111/nyas.12813. Epub 2015 Jul 14. Review.

4.

Effective heritable gene knockdown in zebrafish using synthetic microRNAs.

Giacomotto J, Rinkwitz S, Becker TS.

Nat Commun. 2015 Jun 8;6:7378. doi: 10.1038/ncomms8378.

5.

Motoneuron development influences dorsal root ganglia survival and Schwann cell development in a vertebrate model of spinal muscular atrophy.

Hao le T, Duy PQ, Jontes JD, Beattie CE.

Hum Mol Genet. 2015 Jan 15;24(2):346-60. doi: 10.1093/hmg/ddu447. Epub 2014 Sep 1.

6.

Fishing for causes and cures of motor neuron disorders.

Patten SA, Armstrong GA, Lissouba A, Kabashi E, Parker JA, Drapeau P.

Dis Model Mech. 2014 Jul;7(7):799-809. doi: 10.1242/dmm.015719. Review.

7.

Antisense oligonucleotide mediated therapy of spinal muscular atrophy.

Sivanesan S, Howell MD, Didonato CJ, Singh RN.

Transl Neurosci. 2013 Mar;4(1). doi: 10.2478/s13380-013-0109-2.

8.

In vivo mutation of pre-mRNA processing factor 8 (Prpf8) affects transcript splicing, cell survival and myeloid differentiation.

Keightley MC, Crowhurst MO, Layton JE, Beilharz T, Markmiller S, Varma S, Hogan BM, de Jong-Curtain TA, Heath JK, Lieschke GJ.

FEBS Lett. 2013 Jul 11;587(14):2150-7. doi: 10.1016/j.febslet.2013.05.030. Epub 2013 May 25.

9.

Early interneuron dysfunction in ALS: insights from a mutant sod1 zebrafish model.

McGown A, McDearmid JR, Panagiotaki N, Tong H, Al Mashhadi S, Redhead N, Lyon AN, Beattie CE, Shaw PJ, Ramesh TM.

Ann Neurol. 2013 Feb;73(2):246-58. doi: 10.1002/ana.23780. Epub 2012 Dec 31.

10.

Neuromuscular effects of G93A-SOD1 expression in zebrafish.

Sakowski SA, Lunn JS, Busta AS, Oh SS, Zamora-Berridi G, Palmer M, Rosenberg AA, Philip SG, Dowling JJ, Feldman EL.

Mol Neurodegener. 2012 Aug 31;7:44. doi: 10.1186/1750-1326-7-44.

11.

Survival motor neuron affects plastin 3 protein levels leading to motor defects.

Hao le T, Wolman M, Granato M, Beattie CE.

J Neurosci. 2012 Apr 11;32(15):5074-84. doi: 10.1523/JNEUROSCI.5808-11.2012.

12.

Aberrant Hedgehog ligands induce progressive pancreatic fibrosis by paracrine activation of myofibroblasts and ductular cells in transgenic zebrafish.

Jung IH, Jung DE, Park YN, Song SY, Park SW.

PLoS One. 2011;6(12):e27941. doi: 10.1371/journal.pone.0027941. Epub 2011 Dec 2.

13.

SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals.

Torres-Benito L, Neher MF, Cano R, Ruiz R, Tabares L.

PLoS One. 2011;6(10):e26164. doi: 10.1371/journal.pone.0026164. Epub 2011 Oct 12.

14.

Induced pluripotent stem cells in the study of neurological diseases.

Saporta MA, Grskovic M, Dimos JT.

Stem Cell Res Ther. 2011 Sep 21;2(5):37. doi: 10.1186/scrt78. Review.

Supplemental Content

Support Center